References
Kudoh S, Timmerman P, van Amsterdam P, Arnold M, Garofolo F, Savale S, et al. Global Harmonization on Regulated Bioanalysis and Global Bioanalysis Consortium: a historic perspective on the evolution of regulated bioanalysis since 1990 and why globalization requires harmonization. Pharm Tech Japan. 2012;28(3):489–99.
Shah VP, Midha KK, Dighe S, et al. Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies. Pharm Res. 1992;9:588–92.
Shah V, Midha K, Findlay J, et al. Bioanalytical method validation—a revisit with a decade of progress. Pharm Res. 2001;17(12):1551–7.
Guidance for Industry Bioanalytical Method Validation U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Veterinary Medicine (CVM) May 2001
Findlay JW, Smith WC, Lee JW, Nordblom GD, Das I, et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J Pharm Biomed Anal. 2000;21(6):1249–73.
DeSilva B, Smith W, Weiner R, Kelley M, Smolec J, et.al. Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of Macromolecules Pharmaceutical Research. Nov 2003. Vol. 20, No. 11.
Viswanathan CT et al. Workshop/conference report—quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. AAPS J. 2007;9(1):E117–22.
Fast DM et al. Workshop report and follow-up—AAPS workshop on current topics in GLP bioanalysis: assay reproducibility for incurred samples—implications of crystal city recommendations. APPS J. 2009;11(2):238–41.
Website: EMEA/CHMP/EWP/192217/2009, Guideline on bioanalytical method validation. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf
Website: MHLW Guideline (Japan). http://bioanalysisforum.jp/images/T130918I0020.pdf#zoom = 100
Website: Anvisa Guideline (Brazil). http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2012/rdc0027_17_05_2012.pdf
Timmerman P, Lowes S, Fast DM, et al. Request for global harmonization of the guidance for bioanalytical method validation and sample analysis. Bioanalysis. 2010;2(4):683.
Bansal S, Arnold M, Garofolo F. International harmonization of bioanalytical guidance. Bioanalysis. 2010;2(4):685–7.
van Amsterdam P, Lausecker B, Luedtke S, et al. Towards harmonized regulations for bioanalysis: moving forward! Bioanalysis. 2010;2(4):689–90.
van Amsterdam P, Arnold M, Bansal S, et al. Building the Global Bioanalysis Consortium: working towards a functional globally acceptable and harmonized guideline on bioanalytical method validation. Bioanalysis. 2010;2(11):1801–3.
Savoie N, Garofolo F, van Amsterdam P, et al. 2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidance. Bioanalysis. 2010;2(12):1945–60.
Young GC, Seymour DR, Dueker SR, Timmerman P, Arjomand A, Nozawa K. New Frontiers—Accelerator Mass Spectrometry (AMS): Recommendation for Best Practices and Harmonization from Global Bioanalysis Consortium Harmonization Team. AAPS J. 2014;16(2).
Bower JF, McClung JB, Watson C, Osumi T, Pastre K. Recommendations and best practices for reference standards and reagents used in bioanalytical method validation. AAPS J. 2014;16(2):352–6.
Verhaeghe T, Barton HH, Hara H, Hucker R, Kelley M, Picard F, et al. Recommendations from the global bioanalysis consortium team a8: documentation. AAPS J. 2014;16(2):240–5.
Kelley M, Beaver C, Stevenson LF, Bamford R, Gegwich P, Katsuhiko Y, et al. Large molecule run acceptance: recommendation for best practices and harmonization from the Global Bioanalysis Consortium Harmonization Team. AAPS J. 2014;16(2):221–5.
Dudal S, Baltrukonis D, Crisino R, Goyal MJ, Joyce A, Österlund K, et al. Assay Formats: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team. AAPS J. 2014;16(2).
Ahene A, Calonder C, Davis S, Kowalchick J, Nakamura T, Nouri P, et al. Automation practices in large molecule bioanalysis: recommendations from group L5 of the global bioanalytical consortium. AAPS J. 2013;16(1):164–71.
Stevenson L, Kelley M, Gorovits B, Kingsley C, Myler H, Österlund K, et al. Large molecule specific assay operation: recommendation for best practices and harmonization from the Global Bioanalysis Consortium Harmonization Team. AAPS J. 2013;16(1):83–8.
Fluhler E, Vazvaei F, Singhal P, Vinck P, Li W, Bhatt J, et al. Repeat Analysis and Incurred Sample Reanalysis: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team. AAPS J. 2014;16(3).
Woolf E, McDougall S, Fast D, Andraus M, Barfield M, Blackburn M, et al. Small Molecule Specific Run Acceptance, Small Molecule Specific Assay Operation, and Small Molecule Chromatographic Run Quality Assessment: Recommendation for best practices and harmonization from the Global Bioanalysis Consortium Harmonization Teams. AAPS J. 2014;16(3).
King LE, Farley E, Imazato M, Keefe J, Khan M, Ma M, et al. Ligand Binding Assay Critical Reagents and Their Stability: Recommendations and Best Practices from the Global Bioanalysis Consortium Harmonization Team. AAPS J. 2014;16(3).
van de Merbel N, Savoie N, Yadav M, Ohtsu Y, White J, Riccio MF, et al. Stability: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team. AAPSJ. 2014;16(3).
Briggs RJ, Nicholson R, Vazvaei F, Busch J, Mabuchi M, Mahesh KS, et al. Method Transfer, Partial Validation, and Cross Validation: Recommendations for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team. AAPS J. 2014. doi:10.1208/s12248-014-9650-3.
Sailstad JM, Amaravadi L, Clements-Egan A, Gorovits B, Myler HA, Pillutla RC, et al. White Paper—Consensus and Recommendations of a Global Harmonization Team on Assessing the Impact ofImmunogenicity on Pharmacokinetic Measurements. AAPS J. 2014;16(3):488-98. doi:10.1208/s12248-014-9582-y.
Acknowledgments
Additional founding members: Surendra Bansal (F. Hoffmann-La Roche), Steve Lowes (Quintiles), Douglas Fast (Covance), and Eric Woolf (Merck & Co).
Author information
Authors and Affiliations
Corresponding author
Additional information
Guest Editors: Binodh DeSilva and Philip Timmerman
Janssen Research & Development, Bristol-Myers Squibb Company, Algorithme Pharma, Merck-Serono, Abbott Healthcare Products, Shimadzu Techno-Research, Alkem Laboratories Ltd., ICON Laboratory Services, and CAEP Centro Avançado de Estudos e Pesquisas LTDA are present members of the GBC Steering Committee
Magabi and Keio University Faculty of Pharmacy are past members of the GBC Steering Committee
Philip Timmerman, Mark Arnold, Fabio Garofolo, and Peter van Amsterdam are also Founding Member
Rights and permissions
About this article
Cite this article
Timmerman, P., Arnold, M., DeSilva, B. et al. Introduction to the Proposals from the Global Bioanalysis Consortium Harmonization Team. AAPS J 16, 1159–1161 (2014). https://doi.org/10.1208/s12248-014-9609-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12248-014-9609-4